ASHCROFT PHARMA LIMITEDActive

Company number 09428993Private limited companyIncorporated 2015

Key figures

£347,045+124.5%
Net assets 2024/25
+77.4%
Average annual growth 2019/20–2024/25
0100 k200 k300 k400 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, ASHCROFT PHARMA LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0500 k1 m1.5 m2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand————450,749
Total assets222,946631,244684,516758,5861,302,135
Total liabilities174,884562,402599,570565,814955,090
Net assets / total equity48,06257,14286,746154,572347,045
Average number of employees466810

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: ASHCROFT PHARMA LIMITED

Company

ASHCROFT PHARMA LIMITED is a private limited company registered with Companies House under company number 09428993. It was incorporated on 9 Feb 2015. Its status is active. The registered office is in Bradford (BD7). Its nature of business (SIC 2007) is other professional, scientific and technical activities n.e.c. (74909), other human health activities (86900).

Accounts

The latest accounts in the database are for 2024/25 (period ending 28 Feb 2025); the company files abridged accounts (unaudited). Net assets were £347,045, up 124.5% on the previous year. Cash at bank and in hand was £450,749. Total assets were £1,302,135 and total liabilities £955,090. The company had an average of 10 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 30 Nov 2026. The next confirmation statement is due by 24 Jun 2027.